SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense selling pressure as investors grapple with concerns over the company's significant debt load, capital expenditure for AI data centers, and a recent credit rating downgrade. While the community is sharply divided, with some investors viewing the current price as a deep-value opportunity based on the massive contract backlog, others fear the heavy leverage and potential for further downside if growth targets are not met.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is experiencing significant volatility and trading activity following the announcement of a common stock offering, which has divided market participants between those reacting to dilution and those focused on the stock's clinical potential. The community is heavily debating the company's long-term valuation and future clinical readouts while actively tracking technical breakout levels and potential short-squeeze scenarios.

Factorial Energy, Inc. engages in the development and commercialization of solid-state battery technologies. Its platforms include FEST and Solstice, designed to deliver high-performance, scalable battery solutions for applications in drones, robotics, automotive, and other advanced mobility sectors. The company is headquartered in Billerica, MA.

Factorial Energy Inc. - Ordinary Shares- Class A

Factorial Energy Inc

Factorial Energy is experiencing high volatility as investors react to a new strategic partnership with Tulip Tech aimed at accelerating solid-state battery deployment for drones. While some in the community view the dip as an overreaction to the recent announcement, others are concerned about potential insider selling and long-term liquidity risks following the company's recent SPAC debut.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is in the spotlight as investors digest its latest quarterly results, which featured earnings and revenue beats driven by robust gains in fixed income trading. Market participants are actively discussing the bank's profitability targets alongside broader sector headwinds, including potential legislative pressure on credit card interest rates and the bank's ongoing strategic reorganization.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending as market sentiment shifts following a robust earnings report that showcased significant growth in AI cloud infrastructure and autonomous driving, helping to decouple the stock from broader China tech volatility. Investors are actively debating the valuation gap between Baidu's dominant AI search capabilities and its current market price, with community discussions heavily focused on the potential upside of an upcoming chip unit IPO and the company's expanding international footprint.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is facing heightened market scrutiny as investors weigh recent regulatory approvals for its test reactor against ongoing concerns over share dilution and the absence of commercial revenue. Community discussion is sharply divided, with bulls highlighting the stock as a long-term infrastructure play in the AI energy boom, while bears point to executive selling and missed operational milestones as reasons for continued downward pressure.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The GDX gold mining ETF is seeing renewed investor interest as community sentiment shifts, driven by central bank buying of physical gold and expectations that monetary policy will need to accommodate massive government debt. Traders are closely monitoring technical support levels while debating whether the current environment of high inflation and geopolitical tension signals a long-term structural breakout for the precious metals sector.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending as investors focus on upcoming clinical trial data and the company's platform potential in treating solid tumors. The community is actively discussing the synergistic promise of the Alpha DaRT technology when combined with Merck's Keytruda, fueling bullish sentiment ahead of key presentations and data readouts.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings Ltd. is trending due to a significant $1 billion all-stock acquisition deal involving ACEA Pharma, which has sparked intense speculation about its potential as a low-float volatility play. The community is actively divided, with many traders debating the stock's susceptibility to pump-and-dump mechanics and frequent trading halts, while others are aggressively seeking re-entry points in hopes of a massive short squeeze.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

Lightpath Technologies is trending due to heightened investor interest in its specialized infrared optics and sensor technology, which are increasingly critical for national defense and the expanding physical AI infrastructure. The community is actively discussing strong institutional ownership and potential defense contract opportunities, viewing recent market volatility as a base-building period for a company well-positioned in the drone, space, and counter-UAS sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Repligen Corp. (RGEN) Fell 28% in Q1

Here's Why Repligen Corp. (RGEN) Fell 28% in Q1...

Repligen (RGEN) Dropped Following the Earnings Release

Repligen (RGEN) Dropped Following the Earnings Release...

Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?

Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

JPMorgan Chase & Co. Lowers Repligen (NASDAQ:RGEN) Price Target to $165.00

JPMorgan Chase & Co. dropped their target price on Repligen from $180.00 to $165.00 and set an "overweight" rating for the company in a research report on Wednesday...

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

RGEN tops Q1 earnings and revenue estimates, sending shares higher as strong chromatography and analytics business aid growth. The company raises its 2026 EPS view.

Repligen Corporation $RGEN Stock Position Decreased by UBS Group AG

UBS Group AG lessened its holdings in shares of Repligen Corporation (NASDAQ:RGEN - Free Report) by 23.8% in the fourth quarter, according to the company in its most recent filing with the Securities...

Repligen Q1 Earnings Call Highlights

Repligen (NASDAQ:RGEN) reported first-quarter 2026 results that management said reflected broad-based demand across end markets and geographies, alongside margin expansion driven by mix, pricing, and volume leverage. The company also updated full-year guidance to reflect the divestiture of its Polym...

Repligen (NASDAQ:RGEN) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Repligen (NASDAQ:RGEN - Get Free Report) issued its earnings results on Tuesday. The biotechnology company reported $0.48 earnings per share for the quarter, topping analysts' consensus estimates of...

Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates

Repligen (RGEN) delivered earnings and revenue surprises of +24.97% and +1.53%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Repligen (NASDAQ:RGEN) Updates FY 2026 Earnings Guidance

Repligen (NASDAQ:RGEN) updated its FY 2026 earnings guidance. The company provided EPS guidance of 1.970-2.050 for the period, compared to the consensus estimate of 1.970. The company also issued...

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Repligen Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.45	--	--	N/A
Q1 '26	$0.38	$0.48	25.05%	BEAT
Q4 '25	$0.44	$0.49	11.06%	BEAT
Q3 '25	$0.42	$0.46	10.09%	BEAT
Q2 '25	$0.39	$0.37	-4.70%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

RGENRepligen Corp.

Upcoming Earnings: Q2 '26

Historical Earnings

Latest RGEN News